109 related articles for article (PubMed ID: 9826456)
1. Cytogenetics of uterine sarcomas: presentation of eight new cases and review of the literature.
Iliszko M; Mandahl N; Mrózek K; Denis A; Pandis N; Pejovic T; Babińska M; Nedoszytko B; Debniak J; Emerich J; Hrabowska M; Bloomfield CD; Limon J
Gynecol Oncol; 1998 Nov; 71(2):172-6. PubMed ID: 9826456
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic profile of uterine sarcomas.
Laxman R; Currie JL; Kurman RJ; Dudzinski M; Griffin CA
Cancer; 1993 Feb; 71(4):1283-8. PubMed ID: 8382105
[TBL] [Abstract][Full Text] [Related]
3. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
5. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
7. Polysomy 8 in three cases of homologous malignant mixed Müllerian tumors of the uterus.
Gunawan B; Baumhoer D; Schulten HJ; Emons G; Füzesi L
Anticancer Res; 2003; 23(2B):1379-83. PubMed ID: 12820397
[TBL] [Abstract][Full Text] [Related]
8. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
9. ERBB-2 gene overexpression and amplification in uterine sarcomas.
Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
[TBL] [Abstract][Full Text] [Related]
10. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
[TBL] [Abstract][Full Text] [Related]
11. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
Chu PG; Arber DA; Weiss LM; Chang KL
Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization.
Halbwedl I; Ullmann R; Kremser ML; Man YG; Isadi-Moud N; Lax S; Denk H; Popper HH; Tavassoli FA; Moinfar F
Gynecol Oncol; 2005 May; 97(2):582-7. PubMed ID: 15863163
[TBL] [Abstract][Full Text] [Related]
13. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature.
Euscher ED; Deavers MT; Lopez-Terrada D; Lazar AJ; Silva EG; Malpica A
Am J Surg Pathol; 2008 Feb; 32(2):219-28. PubMed ID: 18223324
[TBL] [Abstract][Full Text] [Related]
14. Complex karyotypic alterations in an endometrial stromal sarcoma.
Hrynchak M; Horsman D; Salski C; Berean K; Benedet JL
Cancer Genet Cytogenet; 1994 Oct; 77(1):45-9. PubMed ID: 7923082
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas.
Coosemans A; Nik SA; Caluwaerts S; Lambin S; Verbist G; Van Bree R; Schelfhout V; de Jonge E; Dalle I; Jacomen G; Cassiman JJ; Moerman P; Vergote I; Amant F
Eur J Cancer; 2007 Jul; 43(10):1630-7. PubMed ID: 17531467
[TBL] [Abstract][Full Text] [Related]
17. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
[TBL] [Abstract][Full Text] [Related]
18. Uterine sarcoma.
Belgrad R; Elbadawi N; Rubin P
Radiology; 1975 Jan; 114(1):181-8. PubMed ID: 1208858
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
Rao UN; Finkelstein SD; Jones MW
Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathological analysis on 106 cases with uterine sarcoma].
Liao Q; Wang J; Han J
Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):104-7. PubMed ID: 11783345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
